2025 annual financial data
Xenon Pharmaceuticals 2025 Operating margin
Xenon Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -4,974.27%.
Operating income was -373,070,000 USD and net income was -345,910,000 USD.
Operating cash flow was -279,118,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,500,000 USD
- Operating income
- -373,070,000 USD
- Net income
- -345,910,000 USD
- Operating cash flow
- -279,118,000 USD